BRIACELL THERAPEUTICS CORP. (BCTXZ) Operating cash flow 2021–2026
BRIACELL THERAPEUTICS CORP. (BCTXZ) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$28.7MFY2026 · since FY2021: -$7.8M → -$28.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$28.7M | -1.7% |
| FY2025 | -$28.2M | -16.8% |
| FY2024 | -$24.1M | -1.6% |
| FY2023 | -$23.7M | -90.2% |
| FY2022 | -$12.5M | -61.1% |
| FY2021 | -$7.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BCTXZ financial trends
BCTXZ RevenueBCTXZ Net incomeBCTXZ Net marginBCTXZ Gross profitBCTXZ Gross marginBCTXZ Operating incomeBCTXZ Operating marginBCTXZ Free cash flowBCTXZ Capital expendituresBCTXZ Return on equityBCTXZ Stock buybacksBCTXZ Dividends paidBCTXZ Total assetsBCTXZ Total liabilitiesBCTXZ Shareholders’ equityBCTXZ overview →